Phase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II)
Hainsworth, John D., Becker, Kevin P., Mekhail, Tarek, Chowdhary, Sajeel A., Eakle, Janice Faulkner, Wright, David, Langdon, Robert M., Yost, Kathleen J., Padula, Gilbert Darin Anthony, West-Osterfield, Kimberly, Scarberry, Meredith, Shaifer, Candice A., Shastry, Mythili, Burris, Howard A., Shih, Kent
Published in Journal of neuro-oncology (01.09.2019)
Published in Journal of neuro-oncology (01.09.2019)
Get full text
Journal Article
HEMOPHAGOCYTIC SYNDROME: AN EBV-INDUCED PHENOMENON IN A HEALTHY HOST?
Eakle, Janice Faulkner, Bressoud, Phillip
Published in Southern medical journal (Birmingham, Ala.) (01.11.1999)
Published in Southern medical journal (Birmingham, Ala.) (01.11.1999)
Get full text
Journal Article
PRIMARY PANCREATIC LYMPHOMA: MINIMALLY INVASIVE DIAGNOSIS AND TREATMENT OF A RARE TUMOR
Eakle, Janice Faulkner, Yam, Lung T.
Published in Southern medical journal (Birmingham, Ala.) (01.11.1999)
Published in Southern medical journal (Birmingham, Ala.) (01.11.1999)
Get full text
Journal Article